Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 72, Issue 6, Pages 974-989
Publisher
Wiley
Online
2017-12-09
DOI
10.1111/his.13452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods
- (2016) Cornelia M. Focke et al. BREAST CANCER RESEARCH AND TREATMENT
- Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining
- (2016) Rasmus Røge et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phosphohistone H3 expression correlates with manual mitotic counts and aids in identification of “hot spots” in fibroepithelial tumors of the breast
- (2016) Paula S. Ginter et al. HUMAN PATHOLOGY
- Digital image analysis outperforms manual biomarker assessment in breast cancer
- (2016) Gustav Stålhammar et al. MODERN PATHOLOGY
- Ki-67 acts as a biological surfactant to disperse mitotic chromosomes
- (2016) Sara Cuylen et al. NATURE
- Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers
- (2016) Mattias Rantalainen et al. Scientific Reports
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Optimizing HER2 assessment in breast cancer: application of automated image analysis
- (2015) Henrik Holten-Rossing et al. BREAST CANCER RESEARCH AND TREATMENT
- Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients
- (2015) Zac Gerring et al. HISTOPATHOLOGY
- The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer
- (2015) Matthias Christgen et al. HUMAN PATHOLOGY
- An international study to increase concordance in Ki67 scoring
- (2015) Mei-Yin C Polley et al. MODERN PATHOLOGY
- Validation of mitosis counting by automated phosphohistone H3 (PHH3) digital image analysis in a breast carcinoma tissue microarray
- (2015) B.F. Dessauvagie et al. PATHOLOGY
- The Utility of Phosphohistone H3 in Breast Cancer Grading
- (2015) Xiaoyan Cui et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- A novel model for Ki67 assessment in breast cancer
- (2014) Quinci Romero et al. Diagnostic Pathology
- Immunohistochemical assessment of Ki67 with antibodies SP6 and MIB1 in primary breast cancer: a comparison of prognostic value and reproducibility
- (2014) Maria Ekholm et al. HISTOPATHOLOGY
- Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
- (2014) Peter Eirew et al. NATURE
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer
- (2013) Carmen Criscitiello et al. BREAST
- Low concordance of biomarkers in histopathological and cytological material from breast cancer
- (2013) Gustav Stålhammar et al. HISTOPATHOLOGY
- Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
- (2012) S. Guiu et al. ANNALS OF ONCOLOGY
- Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma
- (2012) Patricia S Nielsen et al. MODERN PATHOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
- (2011) Pilar Eroles et al. CANCER TREATMENT REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Histological grade of invasive carcinoma of the breast assessed on needle core biopsy - modifications to mitotic count assessment to improve agreement with surgical specimens
- (2011) Anne-Marie O’Shea et al. HISTOPATHOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- A scaling normalization method for differential expression analysis of RNA-seq data
- (2010) Mark D Robinson et al. GENOME BIOLOGY
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer
- (2009) Marie Klintman et al. MODERN PATHOLOGY
- Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma
- (2008) Emad A. Rakha et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation